AMICUS THERAPEUTICS INC. - COMMON STOCK

Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union

27 6 2023 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces First Quarter 2023 Financial Results and Corporate Updates

10 5 2023 07:00:02 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Bank of America 2023 Health Care Conference

02 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce First Quarter 2023 Financial Results on May 10, 2023

01 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Receives Positive CHMP Opinion for Opfolda® (miglustat) for Late-Onset Pompe Disease

26 4 2023 13:00:33 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease

27 3 2023 07:00:09 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Full-Year 2022 Financial Results and Corporate Updates

01 3 2023 07:00:02 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Cowen 43rd Annual Health Care Conference

27 2 2023 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th Annual WORLDSymposium™ 2023

22 2 2023 17:00:08 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023

14 2 2023 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentations and Posters at the 19th Annual WORLDSymposium™ 2023

13 2 2023 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the SVB Securities Global Biopharma Conference

08 2 2023 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Reports Preliminary 2022 Revenue and Provides 2023 Strategic Outlook

09 1 2023 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 1 2023 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Receives Positive CHMP Opinion for Pombiliti™ (cipaglucosidase alfa) for Late-Onset Pompe Disease

16 12 2022 08:10:56 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Stifel 2022 Healthcare Conference

15 11 2022 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Provides EU Regulatory Update for AT-GAA

07 11 2022 12:20:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates

07 11 2022 07:00:01 提供 Nasdaq GlobeNewswire

U.S. FDA Defers Action on Filing for AT-GAA in Late-onset Pompe Disease

28 10 2022 16:01:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022

27 10 2022 07:00:01 提供 Nasdaq GlobeNewswire